PIK3R1 negatively regulates the epithelial-mesenchymal transition and stem-like phenotype of renal cancer cells through the AKT/GSK3β/CTNNB1 signaling pathway

Scientific Reports
Youcheng LinSong Wu

Abstract

The phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT) pathway has been identified as an important pathway in renal cell carcinoma (RCC). We have reported a nonsense mutation in PIK3R1, which encodes the regulatory subunit of PI3K, in a metastatic RCC (mRCC), while the mutation was absent in the corresponding primary RCC (pRCC). To identify the function of PIK3R1 in RCC, we examined its expression in normal kidney, pRCC and mRCC by immunohistochemistry and real-time polymerase chain reaction. The expression of PIK3R1 significantly decreased in pRCC and was further reduced in mRCC compared with normal tissue. Besides, its expression levels were negatively correlated with T-category of tumor stage. Additionally, 786-O and A-704 cells with PIK3R1 depletion introduced by CRISPR/Cas9 system displayed enhanced proliferation, migration and epithelial-mesenchymal transition (EMT), and acquired a stem-like phenotype. Moreover, the PIK3R1 depletion promoted the phosphorylation of AKT in the cells. The knockdown of AKT by shRNA reduced p-GSK3β and CTNNB1 expression in the cells, while the depletion of CTNNB1 impaired stem-like phenotype of the cells. Overall, PIK3R1 down-regulation in RCC promotes propagation, migration, EMT and stem...Continue Reading

References

Jan 9, 2004·Proceedings of the National Academy of Sciences of the United States of America·Toru KondoTetsuya Taga
Nov 9, 2004·Current Opinion in Cell Biology·Craig T Jordan
Mar 29, 2006·The Journal of Cell Biology·Jonathan M LeeErik W Thompson
Jul 19, 2006·Nature Reviews. Genetics·Jeffrey A EngelmanLewis C Cantley
Oct 4, 2007·Proceedings of the National Academy of Sciences of the United States of America·Jiangbing ZhouYing Zhang
Feb 5, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Li LiGraham Casey
Sep 17, 2008·Oncogene·T L Yuan, L C Cantley
Jan 1, 2009·Proceedings of the National Academy of Sciences of the United States of America·Anna DubrovskaVenkateshwar A Reddy
Mar 10, 2009·Lancet·Brian I RiniBernard Escudier
Mar 24, 2009·Biochemical and Biophysical Research Communications·Wei YanMin Luo
Dec 1, 2009·Cell·Jean Paul ThieryM Angela Nieto
Dec 8, 2009·Cancer Cell·Bijay S JaiswalSomasekar Seshagiri
Feb 25, 2010·Annals of Surgical Oncology·Stephen B Edge, Carolyn C Compton
Mar 3, 2010·Annual Review of Biophysics·Beáta Bugyi, Marie-France Carlier
Mar 10, 2011·Nature Medicine·Hans Clevers
Aug 8, 2012·The Journal of Cell Biology·Irène Baccelli, Andreas Trumpp
Nov 13, 2012·Molecular Oncology·Purificación MuñozManel Esteller
Jan 5, 2013·Science·Le CongFeng Zhang
Jan 29, 2013·Journal of the National Cancer Institute·Gongda Xue, Brian A Hemmings
Jun 19, 2013·Experimental Cell Research·Takanori TsukamotoHiroyuki Tsuchiya
Jun 21, 2013·International Journal of Cancer. Journal International Du Cancer·Kaijie HeAmir Goldkorn
Jun 25, 2013·Nature·UNKNOWN Cancer Genome Atlas Research Network
Sep 26, 2013·Nature Reviews. Cancer·Benjamin Beck, Cédric Blanpain
Nov 16, 2013·BMC Cancer·Magdalena CizkovaIvan Bièche
Dec 7, 2013·International Journal of Cancer. Journal International Du Cancer·Yi HuangZhiming Cai
Feb 1, 2014·Nature Reviews. Drug Discovery·David A Fruman, Christian Rommel

❮ Previous
Next ❯

Citations

Sep 18, 2015·Stem Cell Research & Therapy·Mohammed I KhanCezary Szczylik
Sep 5, 2015·Evidence-based Complementary and Alternative Medicine : ECAM·Narumol Bhummaphan, Pithi Chanvorachote
Oct 13, 2017·Biometrics·Yang NiYuan Ji
Feb 11, 2016·Cancer Medicine·Roy Nofech-MozesGeorge M Yousef
Apr 30, 2017·Reproduction : the Official Journal of the Society for the Study of Fertility·Abolfazl BahramiAli Najafi
Sep 22, 2018·Molecular Human Reproduction·S WarrierB Heindryckx
May 26, 2018·Nucleic Acids Research·Rafael Hernández-de-DiegoAna Conesa
Dec 21, 2016·Molecular Cancer·Klaudia K BrodaczewskaAnna M Czarnecka
Dec 1, 2018·Biological Research·Xuejun AiTianpeng Jiang
Apr 26, 2020·Molecular Biology Reports·Ningni JiangJuan Peng
Jun 19, 2019·Breast Cancer Research and Treatment·Sanja B TurturroMelody A Cobleigh
Feb 3, 2020·Cellular and Molecular Life Sciences : CMLS·Reza MohammadinejadIman Azimi
May 10, 2020·Nature Communications·Ling RaoLydia W T Cheung
May 6, 2020·Scientific Reports·Lavanya KalaimaniGowri Priya Chidambaranathan
Aug 3, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Zhao YangTingyi Wen
Jul 4, 2021·Journal of Clinical Laboratory Analysis·Yijun WangLingjun Zhao
Oct 17, 2020·Briefings in Bioinformatics·Peifeng Ruan, Shuang Wang

❮ Previous
Next ❯

Datasets Mentioned

BETA
AB98952

Methods Mentioned

BETA
immunoprecipitation
biopsy
biopsies
surgical resection
PCR
xenografts
flow cytometry

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

CRISPR in Cancer

CRISPR-Cas system enables the editing of genes to create or correct mutations. Given that genome instability and mutation is one of the hallmarks of cancer, the CRISPR-Cas system is being explored to genetically alter and eliminate cancer cells. Here is the latest research.